|
Subject: monovalent counterion donor chem. In one embodiment, the pharmaceutical composition of the present invention comprises a combination of a) at least one liposome having a particle forming component selected from a phospholipid or a mixture of at least one phospholipid, and cholesterol, b) at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof; (c) at least one monovalent counterion donor or a pharmaceutically acccptablc salt thereof; and (d) an amphipathic therapeutic agent, a derivative thereof, or a pharmaceutically acceptable salt thereof.Как перевести monovalent counterion donor?
|
